Advance in studies on biotransformation of flavonoids by intestinal bacteria

Zhongguo Zhongyao Zazhi

Volumn 38, Issue 19, 2013, Pages 3239-3245

  Pan, Ya Ping ^a,b   Zhang, Zhen Hai ^a   Ding, Dong Mei ^a   Jia, Xiao Bin ^a  

^a KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Biotransformation; Flavonoids; Impacting factor; Intestinal bacteria; Reaction type

Indexed keywords

FLAVONOID;

DRUG TRANSFORMATION; INTESTINE FLORA; NONHUMAN; REVIEW;

ANIMALS; BACTERIA; BIOTRANSFORMATION; FLAVONOIDS; HUMANS; INTESTINES;

EID: 84890396776     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20131904     Document Type: Review

References (52)

1. Rathee P, Chaudhary H, Rathee S, et al. Mechanism of action of flavonoids as anti-inflammatory agents: a review [J]. Inflamm Allergy Drug Targets, 2009, 8(3): 229.
2. Grassi D, Desideri G, Croce G, et al. Flavonoids, vascular function and cardiovascular protection [J]. Curr Pharm Des, 2009, 15 (10): 1072.
3. Setchell K D, Brown N M, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones [J]. J Nutr, 2002, 132(12): 3577.
4. Lee Y H, Kwak J, Choi H K, et al. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity [J]. Int J Mol Med, 2012, 30(1): 69.
5. 2011, 42(11): 2335.
6. Ley R E, Peterson D A, Gordon J I. Ecological and evolutionary forces shaping microbial diversity in the human intestine [J]. Cell, 2006, 124(4): 837.
7. Qin J, Li R, Arumugam M, et al. A human gut microbial gene catalogue established by metagenomic sequencing [J]. Nature, 2010, 464(7285): 59.
8. Wang Z, Elizabeth K, Brian J. B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease [J]. Nature, 2011, 472(7341): 57.
9. 2005, 4(4): 39.
10. 2006, 5(3): 30.
11. Zhang C, Zhang M, Pang X, et al. Structural resilience of the gut microbiota in adult mice under high-fat dietary perturbations [J]. ISME J, 2012, 6(10): 1848.
12. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome [J]. Nature, 2011, 473(7346): 174.
13. Claesson M J, Jeffery I B, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly [J]. Nature, 2012, 488(7410): 178.
14. 2011, 36(1): 19.
15. 2010, 34(5): 79.
16. Schneider H, Blaut M. Anaerobic degradation of flavonoids by Eubacterium ramulus [J]. Arch Microbiol, 2000, 173(1): 71.
17. Schoefer L, Mohan R, Schwiertz A, et al. Anaerobic degradation of flavonoids by Clostridium orbiscindens [J]. Appl Environ Microbiol, 2003, 69(10): 5849.
18. Braune A, Blaut M. Intestinal bacterium Eubacterium cellulosolvens deglycosylates flavonoid C-and O-glucosides [J]. Appl Environ Microbiol, 2012, 78(22): 8151.
19. 2009, 49(4): 479.
20. Kim D H, Jung E A, Sohng I S, et al. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities [J]. Arch Pharm Res, 1998, 21(1): 17.
21. Jin J S, Nishihata T, Kakiuchi N, et al. Biotransformation of C-glucosylisoflavone puerarin to estrogenic (3S)-equol in co-culture of two human intestinal bacteria [J]. Biol Pharm Bull, 2008, 31(8): 1621.
22. Nakamura K, Nishihata T, Jin J S, et al. The C-glucosyl bond of puerarin was cleaved hydrolytically by a human intestinal bacterium strain PUE to yield its aglycone daidzein and an intact glucose [J]. Chem Pharm Bull, 2011, 59(1): 23.
23. 2011, 36(4), 443.
24. Hur H G, Lay J O Jr, Beger R D, et al. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin [J]. Arch Microbiol, 2000, 174(6): 422.
25. Blaut M, Schoefer L, Braune A. Transformation of flavonoids by intestinal microorganisms [J]. Int J Vitam Nutr Res, 2003, 73 (2): 79.
26. Schoefer L, Braune A, Blaut M. Cloning and expression of a phloretin hydrolase gene from Eubacterium ramulus and characterization of the recombinant enzyme [J]. Appl Environ Microbiol, 2004, 70(10): 6131.
27. Tsuji H, Moriyama K, Nomoto K, et al. Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS [J]. Arch Microbiol, 2010, 192(4): 279.
28. Tsuji H, Moriyama K, Nomoto K, et al. Identification of an enzyme system for daidzein-to-equol conversion in Slackia sp. strain NATTS [J]. Appl Environ Microbiol, 2012, 78(4): 1228.
29. Kutschera M, Engst W, Blaut M, et al. Isolation of catechin-converting human intestinal bacteria [J]. J Appl Microbiol, 2011, 111(1): 165.
30. Jin J S, Hattori M. Isolation and characterization of a human intestinal bacterium Eggerthella sp. CAT-1 capable of cleaving the C-ring of (+)-catechin and (-)-epicatechin, followed by p-dehydroxylation of the B-ring [J]. Biol Pharm Bull, 2012; 35 (12): 2252.
31. Meselhy M R, Nakamura N, Hattori M. Biotransformation of (-)-epicatechin 3-O-gallate by human intestinal bacteria [J]. Chem Pharm Bull, 1997, 45(5): 888.
32. Tamura M, Tsushida T, Shinohara K. Isolation of an isoflavone-metabolizing, Clostridium-like bacterium, strain TM-40, from human faeces [J]. Anaerobe, 2007, 13(1): 32.
33. Hur H G, Beger R D, Heinze T M, et al. Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein [J]. Arch Microbiol, 2002, 178(1): 8.
34. Wang X L, Hur H G, Lee J H, et al. Enantioselective synthesis of 5-equol from dihydrodaidzein by a newly isolated anaerobic huaman intestinal bacterium [J]. Appl Environ Microbiol, 2005, 71(1): 214.
35. Yang J, Qian D, Jiang S, et al. Identification of rutin deglycosy-lated metabolites produced by human intestinal bacteria using UP-LC-Q-TOF/MS [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2012, 898: 95.
36. Knaup B, Kahle K, Erk T, et al. Human intestinal hydrolysis of phenol glycosides: a study with quercetin and p-nitrophenol glycosides using ileostomy fluid [J]. Mol Nutr Food Res, 2007, 51 (11): 1423.
37. Rafii F, Davis C, Park M, et al. Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals [J]. Arch Microbiol, 2003, 180 (1): 11.
38. Atkinson C, Frankenfeld C L, Lampe J W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health [J]. Exp Biol Med, 2005, 230(3): 155.
39. 2004, 39(2): 153.
40. Hein E M, Rose K, van't Slot G, et al. Deconjugation and degradation of flavonol glycosides by pig cecal microbiota characterized by fluorescence in situ hybridization (FISH) [J]. J Agric Food Chem, 2008, 56(6): 2281.
41. Lin Y T, Hsiu S L, Hou Y C, et al. Degradation of flavonoid aglycones by rabbit, rat and human fecal flora [J]. Biol Pharm Bull, 2003, 26(5): 747.
42. Simons A L, Renouf M, Murphy P A, et al. Greater apparent absorption of flavonoids is associated with lesser human fecal flavonoid disappearance rates [J]. J Agric Food Chem, 2010, 58 (1): 141.
43. Wang L Q, Meselhy M R, Li Y, et al. The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium [J]. Chem Pharm Bull, 2001, 49(12): 1640.
44. 2010, 18(13): 1360.
45. 2008, 16(19): 2144.
46. Munoz Y, Garrido A, Valladares L. Equol is more active than soy isoflavone itself to compete for binding to thromboxane A (2) receptor in human platelets [J]. Thromb Res, 2009, 123(5): 740.
47. 2003, 28(9): 842.
48. 2006: 7(10): 1510.
49. 2009, 28(6): 370.
50. Martin B. Antibiotic overuse: stop the killing of beneficial bacteria [J]. Nature, 2011, 476(7361): 393.
51. Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota [J]. J Physiol Pharmacol, 2012, 63 (5): 497.
52. 2006, 14(10): 973.